ALB and cancer: We observed that the fusion with the ABD only mildly impaired cellular uptake of “supercharged” monobodies in media with and without albumin (Hantschel lab, unpublished observations) This indicates that the ABD used in this work can be combined with future approaches aiming at delivering functional monobodies to the cytoplasm of cancer cells.